San Francisco Business Times found the Bay Area’s largest year‑end stock sale was about $4 billion in biotech, as local drug developers leaned on secondary offerings to raise cash. Terns was among the biggest raises in December.

One of Elon Musk's attorneys signs discovery briefs by day and runs Clown Cardio classes in LA by night. His dual life has crept into the Musk v. Altman discovery fight.

El Paso celebrated New Year's Eve with a custom-built star drop, reflecting local identity, crafted by Pro-Tech System Solutions' Peter, as part of #NYEInEP and #EPWinterFest events.

EnduraCure, a startup from the University of Utah, is developing degradable polymers to tackle e-waste, offering an environmentally friendly alternative for electronic device disposal.

CDFW announces plans to conduct helicopter captures for wildlife research in northern California, focusing on tracking through GPS collars for species like deer, elk, and gray wolves.

Dozens of suits tied to Oracle EBS breaches could be centralized in Austin; plaintiffs say negligence exposed millions of people’s data.

OpenAI is seeking a Head of Preparedness to tackle AI risks, a role requiring technical expertise and immediate immersion into complex safety challenges.

ORNL achieved significant breakthroughs in AI, quantum computing, nuclear energy, and advanced manufacturing in 2025, with notable projects including new AI supercomputers and advancements in quantum networking.

Southern Hills Hospital says it completed Nevada’s first FDA‑approved minimally invasive repair for complex aortic aneurysms, cutting recovery from weeks to days.

A roughly $3.6B Pentagon award will fund F‑35 maintenance, depot repairs and training through 2026, with Fort Worth handling the lion’s share.

A man was injured in a stabbing during an altercation on Chicago's CTA Blue Line. The victim was taken to the hospital and is in good condition. No arrests have been made, and police are investigating.

A Deep Origin‑led consortium won up to $31.7M from ARPA‑H; La Jolla’s Sanford Burnham Prebys will help build AI and tissue models to predict toxicity and speed drug development.

A provocative billboard campaign and a brazen website called Replacement.AI have landed on San Francisco streets — and people are asking whether it’s art, a stunt, or a warning.